Krisztina Csabafi
Overview
Explore the profile of Krisztina Csabafi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibos K, Bodnar E, Dinh H, Kis M, Marvanykovi F, Kovacs Z, et al.
Pflugers Arch
. 2023 Nov;
476(2):179-196.
PMID: 37989901
Chronic kidney disease (CKD) is associated with anxiety; however, its exact mechanism is not well understood. Therefore, the aim of the present study was to assess the effect of moderate...
2.
Dinh H, Kovacs Z, Kis M, Kupecz K, Sejben A, Szucs G, et al.
Geroscience
. 2023 Nov;
46(2):2463-2488.
PMID: 37987885
The prevalence of chronic kidney disease (CKD) is increasing globally, especially in elderly patients. Uremic cardiomyopathy is a common cardiovascular complication of CKD, characterized by left ventricular hypertrophy (LVH), diastolic...
3.
Csabafi K, Ibos K, Bodnar E, Filkor K, Szakacs J, Bagosi Z
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760887
Previously, we reported that intracerebroventricularly administered kisspeptin-13 (KP-13) induces anxiety-like behavior and activates the hypothalamic-pituitary-adrenal (HPA) axis in rats. In the present study, we aimed to shed light on the...
4.
Dinh H, Kovacs Z, Marvanykovi F, Kis M, Kupecz K, Szucs G, et al.
Sci Rep
. 2023 Aug;
13(1):14046.
PMID: 37640761
Uremic cardiomyopathy is characterized by diastolic dysfunction, left ventricular hypertrophy (LVH), and fibrosis. Dysregulation of the kisspeptin receptor (KISS1R)-mediated pathways are associated with the development of fibrosis in cancerous diseases....
5.
Bagosi Z, Megyesi K, Ayman J, Rudersdorf H, Ayaz M, Csabafi K
Biomedicines
. 2023 Aug;
11(8).
PMID: 37626714
Since the corticotropin-releasing factor (CRF) was isolated from an ovine brain, a growing family of CRF-related peptides has been discovered. Today, the mammalian CRF system consists of four ligands (CRF,...
6.
Simon B, Buzas A, Bokor P, Csabafi K, Ibos K, Bodnar E, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37238959
The aim of the present study was to determine the effects of alcohol intoxication and withdrawal on hypothalamic neurohormones such as corticotropin-releasing factor (CRF) and arginine vasopressin (AVP), and extrahypothalamic...
7.
Simon B, Thury A, Torok L, Foldesi I, Csabafi K, Bagosi Z
Alcohol
. 2023 May;
112:17-24.
PMID: 37236432
The aim of the present study was to determine the effects of binge drinking on anxiety-like, depression-like, and social behavior. The participation of the corticotropin-releasing factor (CRF) receptors (CRF1 and...
8.
Pinter D, Balango B, Simon B, Palotai M, Csabafi K, Dobo E, et al.
Neuropeptides
. 2021 May;
88:102147.
PMID: 33932861
Corticotropin-releasing factor (CRF) and the urocortins (Ucn1, Ucn2 and Ucn3) are structurally related neuropeptides which act via two distinct CRF receptors, CRF1 and CRF2, with putatively antagonistic effects in the...
9.
Ibos K, Bodnar E, Bagosi Z, Bozso Z, Toth G, Szabo G, et al.
Biomedicines
. 2021 Jan;
9(2).
PMID: 33503835
Kisspeptins (Kp) are RF-amide neuropeptide regulators of the reproductive axis that also influence anxiety, locomotion, and metabolism. We aimed to investigate the effects of intracerebroventricular Kp-8 (an N-terminally truncated octapeptide)...
10.
Buzas A, Bokor P, Balango B, Pinter D, Palotai M, Simon B, et al.
Brain Res
. 2019 Feb;
1706:41-47.
PMID: 30722977
The aim of the present study was to investigate the participation of corticotropin-releasing factor (CRF) receptors (CRF1 and CRF2) in the alterations of the dorsal and ventral striatal dopamine release...